Sign inJoin waitlistJoin the waitlist

Prakash Ambady

, Associate Member · Providence Health & Services - Oregon

Credentials: · · · · ·

History

Providence Health & Services - Oregon
Present

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
2011–2012
National Cancer Institute NIH
Drexel University College of Medicine/Hahnemann University
2008–2011
Mercy Catholic Medical Center
2003–2004
VINAYAKA MISSION'S MEDICAL COLLEGE, KARAIKAL, PONDICHERRY UNIV, PONDICHERRY, UT, INDIA
1999–2003

Research

Current and potential imaging applications of ferumoxytol for magnetic resonance imaging
Review · Kidney International · 2017 · 249 citations
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group…
Neuro-Oncology · 2021 · 145 citations
High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma
Neurology · 2014 · 123 citations

EN
Edward Neuwelt
25 papers
RB
Ramon Barajas
17 papers · 1 as a fellow
LS
Laszlo Szidonya
9 papers
CR
Cymon Read
8 papers · 4 as a resident
AR
Ahmed Raslan
7 papers
CV
Csanad Varallyay
7 papers
AD
Aclan Dogan
5 papers
BH
Bronwyn Hamilton
5 papers
MW
Matthew Wood
4 papers
MH
Matthias Holdhoff
4 papers
Seunggu Han
4 papers
SB
Stephen Bowden
4 papers · 4 as a resident

Clinical trials

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
Principal investigator · Recruiting · Phase 2
Providence Health & Services
2024–2029
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Site PI · Recruiting · Phase 3
Ono Pharmaceutical Co., Ltd.
2026–2029